| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO | President &CEO +3 more
4 companies
Kaye Edward M. Md is a Director at SRPT with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 13,430 | $32.27 | $433,385.06 | -7.8% | +16.0% | - | |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sale+OE | 15,001 | $31.13 | $466,958.91 | -4.3% | +12.2% | - | |
| Dec 3, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sale+OE | 2,136 | $30.22 | $64,541.43 | -1.0% | +9.1% | - | |
| Dec 1, 2025 | CYTK Cytokinetics Inc | Director | Sale+OE | 28,064 | $66.72 | $1,872,430.08 | -73.8% | -6.9% | - | |
| Nov 11, 2025 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,175 | $65.08 | $336,789.00 | -34.2% | -4.7% | - | |
| Oct 8, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sale+OE | 25,000 | $30.00 | $750,000.00 | -33.7% | +15.5% | - | |
| Oct 6, 2025 | CYTK Cytokinetics Inc | Director | Sell | 6,757 | $60.00 | $405,420.00 | -40.9% | +1.0% | - | |
| Oct 3, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 42,461 | $25.09 | $1,065,206.37 | -46.4% | +20.9% | - | |
| Sep 30, 2025 | CYTK Cytokinetics Inc | Director | Sell | 6,695 | $55.08 | $368,760.60 | -28.8% | +12.4% | - | |
| Sep 3, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 61,885 | $20.13 | $1,245,697.68 | -14.0% | +50.8% | - |